Valuation: Teva Pharmaceutical Industries Limited

Market Cap 40.45B 0 35.13B 32.62B 30.09B 56.68B 3,861B 57.7B 386B 151B 1,918B 152B 149B 6,449B P/E 2026 *
46.6x
P/E 2027 * 18.9x
Enterprise Value 52.64B 0 45.72B 42.46B 39.16B 73.76B 5,025B 75.1B 503B 197B 2,496B 198B 193B 8,393B EV / Sales 2026 *
3.18x
EV / Sales 2027 * 2.83x
Free-Float
88.61%
Yield 2026 *
-
Yield 2027 * -
1 day+1.14%
1 week+11.48%
Current month+8.57%
1 month+8.57%
3 months+2.89%
6 months+5.74%
Current year+5.85%
1 week 9,450
Extreme 9450
10,970
1 month 9,396
Extreme 9396
10,970
Current year 8,860
Extreme 8860
11,350
1 year 5,305
Extreme 5305
11,350
3 years 3,002
Extreme 3002
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
20,860
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%+11.48% - - 40.42B
-3.87%-1.99%+52.92%+155.71% 1,079B
-3.52%-1.32%+52.97%+52.72% 640B
-1.56%+0.83%+36.83%+73.18% 465B
-2.29%+1.12%+36.13%+30.60% 353B
-2.28%-0.69%+33.42%+39.21% 301B
-3.15%+0.25%+10.63%+13.71% 271B
-2.12%+3.31%+1.82%-39.41% 228B
-0.22%+3.87%+28.04%+64.79% 209B
-1.65%-0.32%+13.66%+71.32% 165B
Average -1.98%+4.83%+29.60%+51.31% 412.19B
Weighted average by Cap. -2.76%+4.86%+38.37%+75.05%

Financials

2026 *2027 *
Net sales 16.57B 0 14.39B 13.37B 12.33B 23.22B 1,582B 23.64B 158B 61.95B 786B 62.22B 60.86B 2,642B 17.29B 0 15.02B 13.95B 12.86B 24.23B 1,651B 24.67B 165B 64.65B 820B 64.94B 63.51B 2,757B
Net income 1.14B 0 989M 918M 847M 1.6B 109B 1.62B 10.87B 4.26B 53.97B 4.27B 4.18B 182B 2.36B 0 2.05B 1.9B 1.75B 3.3B 225B 3.36B 22.52B 8.82B 112B 8.86B 8.66B 376B
Net Debt 12.19B 0 10.59B 9.83B 9.07B 17.08B 1,164B 17.39B 116B 45.58B 578B 45.78B 44.78B 1,944B 8.45B 0 7.34B 6.81B 6.28B 11.83B 806B 12.05B 80.65B 31.58B 400B 31.71B 31.02B 1,347B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
30/07/26 ILA 10,680.00 +1.14% 1,803,433
29/07/26 ILA 10,560.00 +10.17% 2,354,552
28/07/26 ILA 9,585.00 +0.89% 831,774
27/07/26 ILA 9,500.00 -0.84% 1,193,392
24/07/26 ILA 9,580.00 +0.49% 1,325,339
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
34.71USD
Average target price
41.20USD
Spread / Average Target
+18.70%

Quarterly revenue - Rate of surprise